Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily versus alternate-day prednisolone in myasthenia gravis
TCTR20240515008Phase 4Not yet recruiting
- Sponsor
- Siriraj Hospital
- Start
- May 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of prednisolone in myasthenia gravis (MG), sponsored by Siriraj Hospital. Planned start May 2024; status: not yet recruiting.
02
Drugs
prednisolone
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on TCTR20240515008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240515008.